HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 2 October 2019

Specialist services commissioning

NHS England is currently consulting on….

  • Stereotactic Ablative Radiotherapy (SABR) for patients with metachronous extracranial oligometastatic cancer (all ages)
  • Stereotactic Ablative Radiotherapy (SABR) for Hepatocellular Carcinoma (Adults)
  • Haematopoietic stem cell transplantation for sickle cell disease for adults
  • Dolutegravir-rilpivirine for treating HIV-1 in adults
  • Rituximab for refractory Systemic Lupus Erythematosus (SLE) in adults and post pubertal children

Deadlines vary by topic.

Posted by at